Novus Biologicals Announces Relationship with GeneGo

Novus Biologicals and GeneGo, a Thomson Reuters business, have partnered to bring useful resources to bioscience researchers.  Novus' antibody catalog, which represents 10,000+ proteins, is now overlaid with 800+ molecular pathways in GeneGo's MetaCoreTM and MetaDrugTM software suites.

Each MetaCoreTM pathway map allows researchers to overlay their data and zoom in on specific genes, proteins and interactions. By targeting specific pathway items of interest, researchers can then click through to Novus' catalog to view gene-specific and protein-specific products.  The MetaDrugTM application helps researchers during the drug development process.  MetaDrugTM allows researchers to investigate the bioactivity of small molecules, to predict human metabolites, to understand systems pharmacology, and to work on drug target prediction and toxicity analyses.

In addition to this new partnership with GeneGo, Novus also provides a bioinformatics tool on their website called the Novus Explorer.  The Novus Explorer was designed to facilitate scientific exploration of related genes, diseases and pathways based on co-citations in scientific publications.  Researchers may type in their gene, disease or pathway of interest and view relationships with other genes, diseases and pathways.  The Novus Explorer is powered by BEA under license from Biovista.

Visit to jump start your research and use these pathway relationships to find reagents from the Novus antibody catalog.


About Novus Biologicals (

Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science.  Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community.  All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet.  By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.


Release Date: 
Thursday, April 7, 2011 - 06:00